Member info
Dr Christophe ORSSAUD
Substitute
France
Working Group(s): Neuro-Ophthalmology Rare Diseases (WG2), Low Vision Daily Life and Patients Groups (TWG5), Genetic Diagnostics (TWG6), Registries & Epidemiology (TWG7), Research (TWG8), National Integration (TWG9)
Team
HCP Center
The Reference Center for Rare Diseases in Ophthalmology was recognized in 2006
as part of the Rare Diseases Plan 2006-2011, re-labeling in 2017....
contact
OPHTARA – Hôpital Européen Georges Pompidou, Paris, France
Service d'ophtalmologieBât. Lecourbe - RC149 rue de Sèvres
75 015 Paris
France
Clinical trials
2020-004594-43 Completed
A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation.
Interventional
NCT04561466 Recruiting, Active
Study of the efficacy of Befizal® 200mg in the treatment of Leber’s hereditary optic neuropathy
Interventional
NCT00422721 Completed
Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy.
Interventional
NCT02771379 Completed
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
Observational
2017-001215-37 Completed
A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in paediatric and adult patients with Wolfram Syndrome
Interventional